AIP
BEAT

Ameritas Investment Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Ameritas Investment Partners’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,899
Closed -$209K – 3118
2020
Q4 		$209K Hold
2,899
– – 0.01% 1123
2020
Q3 		$132K Hold
2,899
– – 0.01% 1273
2020
Q2 		$131K Hold
2,899
– – 0.01% 1254
2020
Q1 		$112K Hold
2,899
– – 0.01% 1209
2019
Q4 		$134K Buy
2,899
+245
+9% +$10.6K 0.01% 1337
2019
Q3 		$108K Hold
2,654
– – ﹤0.01% 1422
2019
Q2 		$128K Hold
2,654
– – 0.01% 1339
2019
Q1 		$166K Hold
2,654
– – 0.01% 1157
2018
Q4 		$158K Hold
2,654
– – 0.01% 1093
2018
Q3 		$171K Hold
2,654
– – 0.01% 1193
2018
Q2 		$119K Hold
2,654
– – 0.01% 1427
2018
Q1 		$82K Hold
2,654
– – ﹤0.01% 1619
2017
Q4 		$79K Buy
2,654
+289
+12% +$8.37K ﹤0.01% 1647
2017
Q3 		$87K Hold
2,365
– – ﹤0.01% 1552
2017
Q2 		$79K Hold
2,365
– – ﹤0.01% 1623
2017
Q1 		$68K Buy
+2,365
New +$58.6K ﹤0.01% 1647

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Ameritas Investment Partners's BEAT Position: Q1 2021 in Review

Ameritas Investment Partners sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 2,899 shares — an estimated $209K sold.

Ameritas Investment Partners first reported a position in BEAT in Q1 2017 and held it in 16 quarters. The position peaked at $209K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Ameritas Investment Partners reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,899 BioTelemetry, Inc. shares in Q1 2021, an estimated $209K.
  • Ameritas Investment Partners first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 16 quarters.
  • Ameritas Investment Partners's BioTelemetry, Inc. position peaked at $209K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Ameritas Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.